Latest News

FlowOx

Novel PAD treatment may be more cost-effective than standard care, study...

FlowOx therapy (Otivio) delivered as a single annual dose may be a cost-effective treatment for peripheral arterial disease (PAD), a recent study published in...

Features

TWO2

What has TWO2 taught us about the treatment of chronic diabetic...

In a win for proponents of topical oxygen therapy, co-principal investigator of the TWO2 study—a multinational, multicentre, randomised, double-blinded, placebo-controlled trial to evaluate the...
hyperbaric

Decades of data show hyperbaric oxygen therapy belongs in the diabetic...

“Diabetic foot ulcers are very difficult to treat, and the approach should be multi-factorial,” Andrew Applewhite tells iWounds News. “If you do not offload...

Videos

Speaking from four separate rooms in four different corners of the world, William Ennis, Desmond Bell, Michael Edmonds, and William Li expounded over zoom on the myriad ways in which COVID-19 had impacted multidisciplinary wound...

Events

Una Adderley

Una Adderley

William ennis illustration

William Ennis

Mike Edmonds profile on iwounds news

Michael Edmonds